Clinical trials
Phase 2 trials in Ghana
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| GlaxoSmithKline | 4 |
| Cardurion Pharmaceuticals, Inc. | 1 |
| Drugs for Neglected Diseases | 1 |
| FHI 360 | 1 |
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
| International AIDS Vaccine Initiative | 1 |
| International Vaccine Institute | 1 |
| Kwame Nkrumah University of Science and Technology | 1 |
| Medicines Development for Global Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Falciparum | 6 |
| Malaria | 5 |
| Onchocerciasis | 3 |
| Onchocerciasis, Ocular | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Anemia, Sickle Cell | 1 |
| Atherosclerosis | 1 |
| Buruli Ulcer | 1 |
| Coinfection | 1 |
| Dipetalonema Infections | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.